Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Gastroenterology

Journal Scan / Research · January 10, 2024

Standard of Care vs Octreotide in Patients With Angiodysplasia-Related Bleeding

Gastroenterology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Gastroenterology
Standard of care versus Octreotide in Angiodysplasia-related bleeding (the OCEAN study): A Multicenter Randomized Controlled trial
Gastroenterology 2023 Dec 27;.(.)., LCMJ Goltstein, KV Grooteman, LHP Bernts, RCH Scheffer, RJF Laheij, LPL Gilissen, RWM Schrauwen, NC Talstra, AT Zuur, H Braat, M Hadithi, JT Brouwer, WB Nagengast, FA Oort, J Tenthof van Noorden, W Kievit, EJM van Geenen, JPH Drenth

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading